The efficacy of prolonged use of the cytoprotective neuropeptide Cortexin on cognitive impairments was studied in patients with ischemic stroke. A total of 80 patients with first ischemic strokes were studied. Patients of the study group (n = 40) received basal treatment plus 10 mg i.m. Cortexin once daily for 10 days, with repeat courses given at three, six, and nine months during the first year; control patients (n = 40) received only basal treatment. Use of four courses of Cortexin over one year in patients with ischemic stroke promoted stabilization and recovery of cognitive functions, and also minimized the probability of post-stroke cognitive impairments throughout the recovery period.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
E. I. Gusev et al. “The epidemiology of stroke in Russia,” Consilium Medicum, 5, No. 5, 7–11 (2003).
E. I. Gusev and A. N. Bogolepova, Cognitive Impairments in Cerebrovascular Diseases, MEDpress-inform, Moscow (2012).
E. I. Gusev and V. I. Skvortsova, Cerebral Ischemia, Meditsina, Moscow (2001).
E. I. Gusev, V. I. Skvortsova, and L. V. Stakhovskaya, “The epidemiology of stroke in Russia,” Zh. Nevrol. Psikhiat., Stroke Suppl., No. 8, 4–9, (2003).
Yu. A. Duplenkova and E. V. Ippolitova, “Aspects of the neuropsychological rehabilitation of patients with aCVA during the acute phase depending on focus location,” in: Proc. Int. Congr. Neurorehabilitation-2013 (2013), pp. 93–94.
M. M. D’yakonov and P. D. Shabanov, “The question of the neuroprotective actions of peptide agents,” Vestn. Ros. Voen.-Med. Akad., 33, No. 1, 255–258 (2011).
V. V. Zakharov and A. Yu. Kovtun, The Diagnosis of Vascular Cognitive Impairments, Moscow (2011).
V. V. Zakharov, “Neuropsychological tests. Needs and potential for application,” Consilium Medicum, 13, No. 2, 82–90.
O. S. Levin, M. A. Dudarova, and N. I. Usol’tseva, “Diagnosis and treatment of poststroke cognitive impairments,” Consilium Medicum, 12, No. 2, 5 (2010).
A. A. Skoromets and A. A. D’yakonov (eds.), Neuroprotection of Acute and Chronic Cerebral Circulatory Failure, Nauka, St. Petersburg (2007).
L. B. Novikova, E. I. Saifullina, and G. G. Valitova, “Treatment of cerebral stroke using neuroprotection at the prehospital stage,” Vestn. Ros. Voen.-Med. Akad., 22, No. 2, 51–56 (2008).
S. A. Rumyantseva, V. A. Stupin, V. V. Afanas’ev, et al., Critical States in Clinical Practice, Med. Kniga., Moscow (2011).
V. I. Skvortsova and E. A. Petrova, “Development of neuroprotective strategies in the treatment of acute ischemic stroke” (2007), www.rlsnet.ru/articles_440.htm.
V. I. Skvortsova and M. A. Evzelman, Ischemic Stroke, Orel (2006).
V. I. Skvortsova et al., “Establishment of a system for provision of medical care in patients with cerebral stroke in the Russian Federation,” in: Proc. All-Russ. Sci.-Appl. Conf. Improvements in the Provision of Medical Care for Patients with Vascular Diseases, Real Taim, Moscow (2011), pp. 13–33.
A. A. Skoromets, L. V. Stakhovskaya, A. S. Belkin, et al., “Cortexin: new potentials in the treatment of ischemic stroke,” in: Neuroprotection in Acute and Chronic Cerebral Circulatory Failure, Nauka, St. Petersburg (2007), pp. 7–17.
A. A. Skoromets, K. T. Aliev, T. V. Lalayan, et al., “Cognitive functions and treatment of their impairments in chronic circulatory failure in the vertebrobasilar system in the elderly,” Zh. Nevrol. Psikhiat., 18, No. 4, 18–24 (2013).
A. P. Skorokhodov and Yu. A. Kabantsev, “Metabolic treatment of ischemic stroke with Cortexin and Nootropil,” Nevrol. Vestn., 33, No. 3–4, 59–60, Kazan (2001).
A. P. Skorokhodov, V. V. Belinskaya,Yu. A. Kobantsev, et al., “Cortexin in the treatment of ischemic and hemorrhagic stroke,” Terra Medica, No. 1, 10–12 (2004).
L. V. Stakhovskaya, M. M. D’yakonov, O. S. Ketlinskaya, and Yu. B. Stepanchuk, “Evidence base for low-dose neuroprotection in acute impairments to cerebral circulation: results of a multicenter study,” Medlain-Ekpress, 210, No. 1, 43–48 (2012).
L. V. Stakhovskaya, K. S. Meshkova, M. N. Dadasheva, et al., “A multicenter, randomized, prospective, double-blind, placebocontrolled study of the safety and efficacy of Cortexin in the acute and early periods of hemisphere ischemic stroke,” Vestn. Ros. Voen.- Med. Akad., 37, No. 1, 238–244 (2012).
P. D. Shabanov, “The pharmacology of peptide agents,” Med. Akad. Zh., 8, No. 4, 3–24 (2008).
N. N. Yakhno, A. B. Lokshina, et al., Dementia: Handbook for Doctors, (2010), http://lb.rus.ec/b/390786/read.
N. N. Yakhno, “Cognitive disorders in the neurology clinic,” Nevrol. Zh., 11, Suppl. 1, 4–12 (2006).
H. Adam et al., “Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial,” Stroke, 24, No. 1, 35–40 (1993).
R. Bonita and R. Beaglehole, “Recovery of motor function after stroke,” Stroke, 19, 1497–1500 (1988).
T. Brott, H. P. Adams, C. P. Olinger, et al., “Measurements of acute cerebral infarction: a clinical examination scale,” Stroke, 20, 864–870 (1989).
F. I. Mahouney and D. Barthel, “Functional evaluation: the Barthel index,” Md. State Med. J., 14, 61–65 (1965).
Author information
Authors and Affiliations
Corresponding author
Additional information
Translated from Zhurnal Nevrologii i Psikhiatrii imeni S. S. Korsakova, Vol. 113, No. 10, Iss. I, pp. 36–39, October, 2013.
Rights and permissions
About this article
Cite this article
Evzel’man, M.A., Aleksandrova, N.A. Cognitive Impairments in Patients with Ischemic Stroke and Their Correction. Neurosci Behav Physi 45, 323–326 (2015). https://doi.org/10.1007/s11055-015-0074-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11055-015-0074-z